← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bloodworks
Seattle, WA
$77,110,239
Total funding
55
Grants
Funding over time
peak $11.3M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$62,667,908 · 49
DOD$14,442,331 · 6
By mechanism
R01$33,554,925 · 20
—$14,442,331 · 6
R35$8,268,896 · 3
P50$7,947,884 · 5
P01$4,691,264 · 6
R34$1,403,584 · 2
Investigators at Bloodworks
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
PATHOGEN-REDUCED, PLASMALYTE-EXTENDED STORED PLATELETS$8,200,928
· FY2012 · Department of the Army
Immunobiology of Transfusion$2,400,023
P01 · FY2018 · HL
Immunobiology of Transfusion$2,374,041
P01 · FY2017 · HL
BIOLOGIC AND IMMUNOLOGIC ASPECTS OF TRANSFUSION MEDICINE$2,110,690
P50 · FY2009 · HL
BIOLOGIC AND IMMUNOLOGIC ASPECTS OF TRANSFUSION MEDICINE$2,063,787
P50 · FY2008 · HL
BIOLOGIC AND IMMUNOLOGIC ASPECTS OF TRANSFUSION MEDICINE$1,973,324
P50 · FY2007 · HL
BIOLOGIC AND IMMUNOLOGIC ASPECTS OF TRANSFUSION MEDICINE$1,973,319
P50 · FY2006 · HL
COLD-STORED PLATELETS TO TREAT BLEEDING IN CARDIAC SURGERY PATIENTS$1,960,825
· FY2020 · Defense Health Agency
GENOMIC TYPING OF RED CELL ANTIGENS$1,675,518
· FY2008 · Department of Defense
Molecular and Translational Studies in Hematologic Disorders$1,276,908
R35 · FY2025 · HL
Molecular and Translational Studies in Hematologic Disorders$1,105,665
R35 · FY2019 · HL
Molecular and Translational Studies in Hematologic Disorders$1,084,583
R35 · FY2020 · HL
Molecular and Translational Studies in Hematologic Disorders$1,083,722
R35 · FY2021 · HL
Molecular and Translational Studies in Hematologic Disorders$1,081,020
R35 · FY2022 · HL
Molecular and Translational Studies in Hematologic Disorders$1,080,109
R35 · FY2023 · HL
Molecular and Translational Studies in Hematologic Disorders$1,052,245
R35 · FY2024 · HL
UNDERSTANDING THE MECHANISMS OF PLATELET ALLOIMMUNIZATION AND ITS PREVENTION$889,734
· FY2008 · Department of Defense
EXTENDED STORAGE OF PATHOGEN-REDUED PLATELET CONCENTRATES$866,326
· FY2013 · Department of Defense
GENOMIC TYPING OF RED CELL ANTIGENS$849,000
· FY2008 · Department of the Army
von Willebrand Factor in Sickle Cell Disease Pathophysiology$776,238
R01 · FY2012 · HL